To our knowledge, this is the first meta-analysis to analyze the effects of HSD17B13 rs72613567: TA allelic variant on the risk of NAFLD in healthy population and viral hepatitis patients. The gene discussed is HSD17B13; the disease is metabolic dysfunction-associated steatotic liver disease.